Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will ...
The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...
The US Food and Drug Administration (FDA) approved expanding the prescribing information for Japanese drugmaker Astellas ...
Kyodo News on MSN10h
China seeks cooperation with Japan amid tariff row with USBEIJING (Kyodo) -- Chinese Commerce Minister Wang Wentao on Tuesday urged Japanese business leaders to "join hands" with ...
News Medical on MSN7h
Radiation, Immunotherapy May Preserve Bladder in CancerPatients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors ...
IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...
(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration approved expanded U.S. Prescribing information for IZERVAY (avacincaptad pegol intravitreal ...
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback